Fig. 2From: Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in JapanFlow chart of patients throughout the study. AE adverse event, CAI Clinical Activity Index, IFX infliximab, UC ulcerative colitisBack to article page